-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AePgnqo6sYshK8mUeeUPJff586Bcp7HMyoNkvEJOF1EenbpsYa9if7sKHBlU59KV tfxsXGmH2wbfu8XjXJOVOg== /in/edgar/work/0000950172-00-001899/0000950172-00-001899.txt : 20001117 0000950172-00-001899.hdr.sgml : 20001117 ACCESSION NUMBER: 0000950172-00-001899 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20001116 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: DEPOMED INC CENTRAL INDEX KEY: 0001005201 STANDARD INDUSTRIAL CLASSIFICATION: [8731 ] IRS NUMBER: 943229046 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: SEC FILE NUMBER: 005-53683 FILM NUMBER: 771613 BUSINESS ADDRESS: STREET 1: 366 LAKESIDE DRIVE CITY: FOSTER CITY STATE: CA ZIP: 94404-1167 BUSINESS PHONE: 6505130990 MAIL ADDRESS: STREET 1: 1170 B CHESS DRIVE CITY: FOSTER CITY STATE: CA ZIP: 94404 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: DRAPKIN DONALD G CENTRAL INDEX KEY: 0001046392 STANDARD INDUSTRIAL CLASSIFICATION: [0000 ] FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: PROXYMED STREET 2: 2555 DAVIE RD STE 110 CITY: FT LAUDERDALE STATE: FL ZIP: 33317 BUSINESS PHONE: 9544731001 MAIL ADDRESS: STREET 1: PROXYMED STREET 2: 2555 DAVIE RD STE 110 CITY: FT LAUDERDALE STATE: FL ZIP: 33317 SC 13D/A 1 0001.txt SC 13D - AMENDMENT NO. 2 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Amendment No. 2) (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(a) DEPOMED, INC. - -------------------------------------------------------------------------- (Name of Issuer) COMMON STOCK, NO PAR VALUE - -------------------------------------------------------------------------- (Title of Class of Securities) 249908104 - -------------------------------------------------------------------------- (CUSIP Number) DONALD G. DRAPKIN 35 E. 62nd St. New York, NY 10021 (212) 572-8440 - -------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) November 14, 2000 - -------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box [ ] NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedules, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent. CUSIP No. 249908104 - ---------------------------------------------------------------------------- 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON. Donald G. Drapkin - ---------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] - ---------------------------------------------------------------------------- 3. SEC USE ONLY - ---------------------------------------------------------------------------- 4. SOURCE OF FUNDS PF - ---------------------------------------------------------------------------- 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e): [ ] - ---------------------------------------------------------------------------- 6. CITIZENSHIP OR PLACE OF ORGANIZATION USA - ---------------------------------------------------------------------------- NUMBER OF 7. SOLE VOTING POWER 598,900 SHARES ------------------------------------------------- BENEFICIALLY OWNED BY EACH 8. SHARED VOTING POWER 0 REPORTING ------------------------------------------------- PERSON WITH: 9. SOLE DISPOSITIVE POWER 598,900 ------------------------------------------------- 10. SHARED DISPOSITIVE POWER 0 11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 598,900 - ---------------------------------------------------------------------------- 12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ] - ---------------------------------------------------------------------------- 13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 8.3% - ---------------------------------------------------------------------------- 14. TYPE OF REPORTING PERSON IN This Amendment No. 2 to Schedule 13D (this "Amendment") is being filed pursuant to Rule 13d-2(a) of the Rules and Regulations under the Securities Exchange Act of 1934, as amended (the "Act"), on behalf of Donald G. Drapkin with respect to the common stock, no par value (the "Common Stock"), of Depomed, Inc., a California corporation (the "Company"). This Amendment amends the Schedule 13D originally filed by Mr. Drapkin on October 13, 2000 (the "Initial Schedule 13D"), as previously amended by Amendment No. 1 to the Initial Schedule 13D filed by Mr. Drapkin on October 23, 2000 (as so amended, the "Schedule 13D"). The Schedule 13D, is hereby further amended by the addition of the following information: ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION. As of November 14, 2000, Mr. Drapkin has invested $2,636,595 of his personal funds to acquire shares of Common Stock. ITEM 5. INTEREST IN SECURITIES OF THE ISSUER. (a)-(b) As of September 30, 2000, based on information provided by the Company, there were 7,189,363 shares of Common Stock outstanding. Mr. Drapkin is currently the beneficial owner of 598,900 shares of Common Stock, representing 8.3% of the Common Stock then outstanding. Mr. Drapkin has the sole power to vote and dispose of the shares of Common Stock held by him. (c) Other than the transactions described in Item 5 of the Schedule 13D or set forth in the table below, there were no transactions by Mr. Drapkin with respect to shares of Common Stock during the past 60 days. The following table sets forth transactions in shares of Common Stock effected by Mr. Drapkin during the past 60 days not previously reported in the Schedule 13D: Date Nature of Transaction Number of Shares Price per Share - ---- --------------------- ---------------- --------------- 10/25/00 Purchase 7,500 $5.25 10/25/00 Purchase 6,000 $5.125 10/25/00 Purchase 4,200 $5.0625 10/25/00 Purchase 300 $5.00 10/25/00 Purchase 300 $4.875 10/25/00 Purchase 1,200 $4.1825 10/25/00 Purchase 6,000 $4.9375 10/26/00 Purchase 500 $5.00 10/27/00 Purchase 900 $5.125 10/27/00 Purchase 5,000 $4.50 10/27/00 Purchase 4,000 $5.375 11/1/00 Purchase 7,000 $5.3125 11/1/00 Purchase 500 $5.25 11/1/00 Purchase 4,000 $5.5625 11/2/00 Purchase 6,500 $5.5625 11/2/00 Purchase 500 $5.375 11/2/00 Purchase 500 $5.25 11/2/00 Purchase 500 $5.0625 11/6/00 Purchase 7,500 $5.50 11/10/11 Purchase 500 $5.50 11/10/00 Purchase 2,000 $5.5625 11/14/00 Purchase 15,000 $5.00 11/14/00 Purchase 300 $4.8125 11/14/00 Purchase 500 $4.6875 11/14/00 Purchase 1,000 $4.50 11/14/00 Purchase 200 $4.625 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: November 16, 2000 /s/ Donald G. Drapkin --------------------------- Donald G. Drapkin -----END PRIVACY-ENHANCED MESSAGE-----